Dr Steven Abramowitz has pioneered a treatment approach for deep venous stent thrombosis using a novel minimally invasive thrombectomy catheter. This procedure marks a significant advancement in addressing the challenging issue of stent occlusion in deep venous disease.
The RevCore catheter, designed by Inari, offers a versatile and effective solution for debulking occlusive material within deep venous stents. With its expandable diameter and ability to address dense scar-like tissue, this catheter fills a critical gap in the treatment options for patients with deep venous stent occlusion.
Dr Abramowitz’s initial experiences with the RevCore catheter have demonstrated exceptional outcomes. Patients who underwent the procedure reported symptomatic improvement, with 100% procedural success rates and excellent patency rates during follow-up. The device’s ease of use and haptic feedback have contributed to its efficacy and positive patient experiences.
As the RevCore catheter becomes commercially available, it has the potential to revolutionize the treatment landscape for deep venous stent thrombosis. Its user-friendly design and effectiveness make it a valuable tool in maintaining primary assisted or secondary patency. With wider adoption and increased operator confidence, this catheter is poised to become a crucial component of venous disease treatment strategies.
The introduction of the RevCore catheter represents a significant leap forward in addressing deep venous stent occlusion. Its success in debulking occlusive material and restoring vessel patency offers hope for patients experiencing recurring symptoms or in-stent thrombosis. With ongoing advancements and increased operator expertise, this innovative catheter holds the potential to transform the lives of individuals affected by deep venous stent thrombosis.
